Pharmacy Department

The Department of Pharmacy of Hangzhou Red Cross Hospital (Zhejiang Provincial Hospital of Integrated Traditional Chinese and Western Medicine) is currently a Zhejiang Provincial Specialty with Distinctive Traditional Chinese Medicine Advantages, a subdiscipline of Hangzhou’s Peak Discipline (Tuberculosis), a member of the Zhejiang Provincial Team for the Inheritance and Innovative Development of Traditional Chinese Medicine in the Diagnosis and Treatment of Geriatric Cardiopulmonary Diseases, and a standardized-construction institution for Therapeutic Drug Monitoring (TDM) of the China Anti-Tuberculosis Consortium; it houses the Trainee Training Base of the Clinical Pharmacy Branch of the Chinese Medical Association and the Integrated Chinese and Western Medicine Pharmacy Research Laboratory of the Zhejiang Institute of Integrated Traditional Chinese and Western Medicine, and is the chairing institution of the Tuberculosis Pharmacy Special Committee of the Zhejiang Anti-Tuberculosis Association and the Clinical Pharmacy Special Committee of the Hangzhou Society of Integrated Traditional Chinese and Western Medicine; it is also a pharmacy master’s training site for Zhejiang Chinese Medical University and Hangzhou Normal University. The Department of Pharmacy has three campuses, namely the Fengqi Campus, Qiantang Campus, and Yisheng Campus, and comprises the Clinical Pharmacy Office (including the TDM Laboratory), Western Medicine Pharmacy (including the Drug Warehouse, Outpatient Pharmacy, Emergency Pharmacy, Inpatient Pharmacy, Centralized Intravenous Admixture Center, Tuberculosis Pharmacy, Infectious Diseases Pharmacy, and GCP Pharmacy), Chinese Medicine Pharmacy (including the Outpatient Chinese Medicine Pharmacy and Chinese Herbal Granule Pharmacy), the On-Prescription Processing Room, and other departments. The Fengqi/Yisheng campuses have 104 pharmacists, and the Qiantang Campus has 53 pharmacists; among them, 3 hold doctorates, accounting for 1.9%, 18 hold master’s degrees, accounting for 11.4%, and 20 hold senior professional titles, accounting for 12.7%. The Department has 2 Zhejiang Provincial Emerging Medical Talents, 2 Hangzhou Emerging Medical Talents, 1 specially supported talent under Hangzhou’s “Pearl of West Lake Project,” 1 Hangzhou Category C talent, 2 master’s supervisors, 2 standing committee members of national-level academic societies, 8 committee members, 1 youth committee member, 1 provincial-level chairperson, 2 vice-chairpersons, 3 municipal-level chairpersons, and 6 vice-chairpersons.

The team takes “serving clinical needs and inheriting the essence of pharmacy” as its mission and is committed to building a high-quality integrated Chinese and Western medicine clinical pharmacy service system. It conducts evaluations of the efficacy and safety of combined Chinese and Western medication use; provides integrated Chinese and Western medicine pharmacy outpatient services and science-popularization education; and has established a model-guided precision medication platform, carrying out a PPK model matrix to achieve dynamic, self-iterating alerts for individualized exposure levels and dose adjustment. It is the first medical institution in the province to provide anti-tuberculosis drug TDM services as its distinctive feature.

The team emphasizes the inheritance and development of traditional Chinese medicine, and has established a quality management system for Chinese herbal decoction pieces and decoction services. As the lead construction unit for Zhejiang’s “One Thing for Traditional Chinese Medicine Prescriptions,” it has built a full-process quality-control system covering raw medicinal materials → procurement → processing and preparation → portioning → acceptance → dispensing → decoction. It attaches importance to the inheritance and dissemination of traditional Chinese medicine culture; one of its projects was selected for Hangzhou’s digital reform project for the inheritance and innovation of traditional Chinese medicine, the “Digital Twin Communication Platform for Traditional Chinese Medicine Culture.” It attaches importance to developing distinctive traditional Chinese medicine products and has developed 26 in-hospital traditional Chinese medicine preparations, various traditional Chinese medicine medicated pastes (Sleep-Aiding and Complexion-Enhancing Paste, Qi-Supplementing and Blood-Nourishing Paste, and Lung-Tonifying and Infection-Prevention Paste), pediatric aromatic essential oil for opening the orifices, traditional Chinese medicine health-preserving tea beverages (such as Sour Plum Beverage, Throat-Clearing and Pharynx-Benefiting Formula, Qingying Formula, Jingcai Yuemu Eye-Refreshing Beverage, and Calming and Sleep-Aiding Formula), traditional Chinese medicine health-preserving medicinal diets, and others.

The team attaches importance to clinical research exploration and translation, and over the past five years has undertaken 62 research projects of various types, including 1 subtask of the National Major Project on Infectious Diseases, 2 National Natural Science Foundation of China projects, 4 Zhejiang Provincial Natural Science Foundation projects, 1 science-and-technology co-construction project of the National Demonstration Zone for Comprehensive Traditional Chinese Medicine Reform, and 24 ministry/department/bureau-level projects; it has also conducted more than 80 Phase I clinical trial projects, with total project revenue reaching 2430.9万元; it has published more than 100 papers in SCI-indexed or core journals, including 35 SCI papers; participated in developing 3 expert consensuses; applied for a total of 4 invention patents, 2 of which obtained software copyrights, and achieved technology transfer; received 2 Hangzhou Health Science and Technology Innovation Awards and 1 Science and Technology Award of the Zhejiang Pharmaceutical Society; and received the Zhejiang Hospital Pharmaceutical Affairs Quality Control Management Excellence Award, among others.